Evidence map›Paper›PMID 41051179›Full record

ReviewJournal of hospital medicine2026

Things We Do for No Reason™: Routinely maintaining intravenous access in hospitalized patients.

Brent Kennis, John P Gerstenberger, Lara Hayes

Abstract readReview
In one paragraph

Review in Journal of hospital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Top unanswered questions in antimicrobial management of necrotizing soft tissue infections.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brent KennisDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.ORCID https://orcid.org/0000-0001-7557-8251
John P GerstenbergerDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
Lara HayesDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral intravenous catheters (PIVCs) are widely used in hospitalized patients and are often maintained even after the need for intravenous therapy has resolved. This article challenges the routine practice of maintaining idle PIVCs in clinically stable patients. While PIVCs offer convenient access for emergent treatment, they are associated with risks-including local infections, phlebitis, and vascular damage-as well as significant patient discomfort. Notably, although PIVCs carry a lower individual risk of bloodstream infection compared with central venous catheters, their widespread use makes them responsible for up to one-third of Staphylococcus aureus catheter-related bacteremia. Furthermore, idle PIVCs often fail before use, and intraosseous access provides an effective alternative in true emergencies. As many intravenous medications can be safely and effectively administered orally, the continued use of PIVCs in stable patients may offer little benefit while introducing avoidable harms and costs. Clinicians should regularly reassess the need for intravenous access and remove idle PIVCs when appropriate to promote patient safety and comfort.

Indexed as

Catheterization, PeripheralCatheter-Related InfectionsCatheters, IndwellingHospitalizationBacteremiaHumans

Identifiers

PMID41051179
PMCPMC12865233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.